United States · Investor

Skyline Ventures

Last cheque observed Mar 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firmWebsite unconfirmed

GrowthPre-seedSeedConsumerConsumer GoodsFinTech

Cheques on record
0%of best year0cheques in 12 months, 49 on record
Since the last cheque4248days00hrs00min00sec
Median round$27MRounds led0 of 49Sole investor1 roundsExits10 from the portfolioMostly inUnited States, 100%
Pitch Skyline Ventures

Skyline Ventures highlights

  1. 01

    49 rounds on record

  2. 02

    Mostly Series B and Series A: 49% of its rounds

  3. 03

    Sole investor in 1 rounds, median $11M

  4. 04

    10 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
GrowthPre-seedSeedSeries ASeries B
Sectors
ConsumerConsumer GoodsFinTech
Based in
Palo Alto, United States
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first49 appearances

  1. 2015

    1 round

  2. Mar
    Collegium PharmaceuticalVenture · US$50MWith 10 others
  3. 2014

    2 rounds

  4. May
    Proteon TherapeuticsSeries D · US$45MWith 9 others
  5. Apr
    SI-BONEVenture · US$33MWith 3 others
  6. 2013

    3 rounds

  7. Dec
    Sutro BiopharmaSeries D · US · finsmes.com$26MWith 5 others
  8. Jul
    Dicerna PharmaceuticalsSeries C · US · finsmes.com$60MWith 8 others
  9. Jan
    Crescendo BioscienceSeries D · US · pevc.dowjones.com$28MWith 4 others
  10. 2012

    3 rounds

  11. Oct
    Genocea BiosciencesSeries C · US · masshightech.com$30MWith 9 others
  12. May
    Sutro BiopharmaSeries C · US · finance.yahoo.com$17MWith 4 others
  13. Feb
    Collegium PharmaceuticalVenture · US · masshightech.com$23MWith 1 other
  14. 2011

    2 rounds

  15. Sept
    SI-BONEVenture · US · finsmes.com$16MWith 1 other
  16. Jan
    Genocea BiosciencesSeries B · US · finsmes.com$35MWith 8 others
  17. 2010

    3 rounds

  18. Nov
    Sutro BiopharmaSeries C · US · finsmes.com$37MWith 4 others
  19. Aug
    SI-BONESeries B · US · onbiovc.com$11MSole investor
  20. Jun
    Tetraphase PharmaceuticalsSeries C · US · fiercebiotech.com$45MWith 7 others
  21. 2009

    5 rounds

  22. Dec
    Genocea BiosciencesSeries B · US$26MWith 7 others
  23. Nov
    Calibra MedicalVenture · US · deals.venturebeat.com$1.4MWith 4 others
  24. Nov
    Calypso MedicalSeries E · US · onbiovc.com$50MWith 3 others
  25. May
    Proteon TherapeuticsSeries B · US · proteontherapeutics.com$50MWith 7 others
  26. Feb
    SpinalMotionSeries C · US · venturebeat.com$500KWith 3 others
  27. 2008

    6 rounds

  28. Aug
    Tetraphase PharmaceuticalsSeries A · US · equityhelpdesk.com$15MWith 4 others
  29. Aug
    InteKrinSeries C · US · deals.venturebeat.com$19MWith 6 others
  30. Aug
    Calibra MedicalSeries B · US$35MWith 4 others
  31. Jul
    Dicerna PharmaceuticalsSeries A · US$8.4MWith 2 others
  32. May
    NovaSysVenture · US · deals.venturebeat.com$50MWith 10 others
  33. Apr
    Concert PharmaceuticalsSeries C · US$37MWith 11 others
  34. 2007

    7 rounds

  35. Sept
    Sequel PharmaceuticalsSeries A · US$20MWith 4 others
  36. Sept
    Proteon TherapeuticsSeries A · US · proteontherapeutics.com$12MWith 3 others
  37. Jul
    MedivanceSeries D · US$23MWith 3 others
  38. Jul
    SatietySeries D · US · venturebeat.com$30MWith 6 others
  39. Jun
    ARCA biopharmaSeries B · US$18MWith 4 others
  40. Mar
    MAP PharmaceuticalsSeries D · US · deals.venturebeat.com$50MWith 5 others
  41. Feb
    Targanta TherapeuticsSeries C · US$70MWith 3 others
  42. 2006

    7 rounds

  43. Nov
    Concert PharmaceuticalsSeries B · US · concertpharma.com$49MWith 7 others
  44. Nov
    Tetraphase PharmaceuticalsSeries A · US$10MWith 4 others
  45. Oct
    TolerxSeries D · US$61MWith 11 others
  46. Sept
    NovaCardiaSeries B · US$48MWith 5 others
  47. Jul
    Concert PharmaceuticalsSeries A · US · concertpharma.com$10MWith 4 others
  48. May
    AvidiaSeries C · US · freshnews.com$44MWith 6 others
  49. May
    KAI PharmaceuticalsSeries B · US · kaipharmaceuticals.com$35MWith 6 others
  50. 2005

    3 rounds

  51. Aug
    iBalance MedicalSeries A · US$8.2MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed10 in all

Crescendo BioscienceBought by Myriad Genetics$270MFeb 2014
MAP PharmaceuticalsBought by Allergan$958MJan 2013
Calibra MedicalBought by Johnson & JohnsonUndisclosedJul 2012
KAI PharmaceuticalsBought by Amgen$315MApr 2012
MedivanceBought by C. R. Bard$250MNov 2011
Calypso MedicalBought by Varian Medical SystemsUndisclosedSept 2011
Guava TechnologiesBought by Millipore$23MFeb 2009
AvidiaBought by Amgen$290MSept 2008
Sirtris PharmaceuticalsBought by GlaxoSmithKline$720MApr 2008
NovaCardiaBought by Merck & Co.$366MSept 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Skyline Ventures. A count of rooms they were both in, not a relationship either has claimed.

Three Arch PartnersGrowth equity9rounds togetherIntersouth PartnersVC firm8rounds togetherTVM CapitalPrivate equity8rounds togetherInterWest PartnersVC firm7rounds togetherAmgenCorporate VC5rounds togetherBrookside CapitalHedge fund5rounds togetherPolaris PartnersVC firm5rounds togetherAbingworthVC firm4rounds togetherAlta PartnersVC firm4rounds togetherDomain AssociatesVC firm4rounds togetherFlagship Pioneering, LLCVC firm4rounds togetherFrazier Healthcare PartnersPrivate equity4rounds together

Quick answers about Skyline Ventures

What does Skyline Ventures invest in?

Skyline Ventures invests most often at Series B and Series A (49% of the rounds on record), in sectors such as Consumer, Consumer Goods and FinTech.

How active is Skyline Ventures?

49 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2015.

How big are Skyline Ventures's cheques?

The median round it joins is $27M.

Does Skyline Ventures lead rounds?

Rarely, if at all: none of its 49 investments on record names it as the lead.

Where does Skyline Ventures invest?

Most of the companies it backs are in the United States (100%).

Is Skyline Ventures investing now?

No investments in the last 12 months; the latest was in Mar 2015.

Who does Skyline Ventures invest alongside?

Most often Three Arch Partners (9 rounds together), Intersouth Partners (8 rounds together) and TVM Capital (8 rounds together).

What kind of investor is Skyline Ventures?

Skyline Ventures is a VC firm based in Palo Alto, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it